No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2pd0C, 0.5552, 2.99, 0.121, 202, 91, PROTEIN CGD2_2020 FROM CRYPTOSPORIDIUM PARVUM
2, 2pd0D, 0.5542, 3.00, 0.121, 200, 91, PROTEIN CGD2_2020 FROM CRYPTOSPORIDIUM PARVUM
3, 2pd0B, 0.5541, 2.99, 0.121, 202, 91, PROTEIN CGD2_2020 FROM CRYPTOSPORIDIUM PARVUM
4, 2pd0A, 0.5532, 3.01, 0.121, 202, 91, PROTEIN CGD2_2020 FROM CRYPTOSPORIDIUM PARVUM
5, 5e3eF, 0.5521, 2.98, 0.133, 113, 90, CRYSTAL STRUCTURE OF CDIA-CT/CDII COMPLEX FROM Y. KRISTENSENII 33638
6, 5e3eB, 0.5482, 3.12, 0.087, 113, 92, CRYSTAL STRUCTURE OF CDIA-CT/CDII COMPLEX FROM Y. KRISTENSENII 33638
7, 5e3eD, 0.5457, 2.92, 0.146, 112, 89, CRYSTAL STRUCTURE OF CDIA-CT/CDII COMPLEX FROM Y. KRISTENSENII 33638
8, 1awzA, 0.5222, 2.97, 0.112, 123, 89, 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H 15N NMR SPECTROSCOPY 30 STRUCTURES
9, 2vq9A, 0.5203, 3.13, 0.112, 123, 89, RNASE ZF-3E
10, 1qwqA, 0.5172, 3.06, 0.080, 124, 88, SOLUTION STRUCTURE OF THE MONOMERIC N67D MUTANT OF BOVINE SEMINAL RIBONUCLEASE
11, 2hkyA, 0.5105, 3.78, 0.065, 129, 93, NMR SOLUTION STRUCTURE OF HUMAN RNASE 7
12, 4owzB, 0.5097, 3.69, 0.086, 134, 93, STRUCTURE OF ECP/H15A MUTANT.
13, 3ljdA, 0.5092, 2.93, 0.128, 126, 86, THE X-RAY STRUCTURE OF ZEBRAFISH RNASE1 FROM A NEW CRYSTAL FORM AT PH 4.5
14, 1k2aA, 0.5092, 3.79, 0.064, 136, 94, MODIFIED FORM OF EOSINOPHIL-DERIVED NEUROTOXIN
15, 3ljdB, 0.5090, 2.93, 0.128, 126, 86, THE X-RAY STRUCTURE OF ZEBRAFISH RNASE1 FROM A NEW CRYSTAL FORM AT PH 4.5
16, 6cyjB, 0.5088, 4.22, 0.049, 329, 103, MYCOBACTERIUM TUBERCULOSIS TRANSCRIPTIONAL REGULATOR 
17, 1a4yB, 0.5082, 3.22, 0.112, 123, 89, RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX
18, 3ln8A, 0.5081, 2.94, 0.128, 126, 86, THE X-RAY STRUCTURE OF ZF-RNASE-1 FROM A NEW CRYSTAL FORM AT PH 7.3
19, 3ln8B, 0.5076, 2.93, 0.128, 126, 86, THE X-RAY STRUCTURE OF ZF-RNASE-1 FROM A NEW CRYSTAL FORM AT PH 7.3
20, 6cyjA, 0.5075, 4.07, 0.069, 329, 102, MYCOBACTERIUM TUBERCULOSIS TRANSCRIPTIONAL REGULATOR 
21, 2bexC, 0.5074, 3.60, 0.086, 135, 93, CRYSTAL STRUCTURE OF PLACENTAL RIBONUCLEASE INHIBITOR IN COMPLEX WITH HUMAN EOSINOPHIL DERIVED NEUROTOXIN AT 2A RESOLUTION
22, 2j4tB, 0.5073, 2.86, 0.116, 119, 86, BIOLOGICAL AND STRUCTURAL FEATURES OF MURINE ANGIOGENIN-4 AN ANGIOGENIC PROTEIN
23, 1b1eA, 0.5070, 3.08, 0.112, 123, 89, CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT K40Q
24, 1agiA, 0.5064, 3.19, 0.122, 125, 90, CRYSTAL STRUCTURE OF BOVINE ANGIOGENIN AT 1.5 ANGSTROMS RESOLUTION
25, 2lvzA, 0.5063, 3.61, 0.075, 133, 93, SOLUTION STRUCTURE OF A EOSINOPHIL CATIONIC PROTEIN-TRISACCHARIDE HEPARIN MIMETIC COMPLEX
26, 4oxfB, 0.5062, 3.56, 0.088, 133, 91, STRUCTURE OF ECP IN COMPLEX WITH CITRATE IONS AT 1.50 ANGSTROMS
27, 2angA, 0.5062, 3.08, 0.112, 123, 89, CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN OF THE MET(-1) FORM
28, 1angA, 0.5061, 3.08, 0.112, 123, 89, CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FROM RIBONUCLEASE
29, 6cz6B, 0.5060, 4.11, 0.068, 321, 103, MYCOBACTERIUM TUBERCULOSIS TRANSCRIPTIONAL REGULATOR 
30, 6cyyB, 0.5055, 4.25, 0.048, 330, 104, MYCOBACTERIUM TUBERCULOSIS TRANSCRIPTIONAL REGULATOR 
31, 4a2yB, 0.5055, 3.57, 0.088, 133, 91, STRUCTURE OF THE HUMAN EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH CITRATE ANIONS
32, 1dytB, 0.5054, 3.58, 0.088, 133, 91, X-RAY CRYSTAL STRUCTURE OF ECP (RNASE 3) AT 1.75 A
33, 6cyyA, 0.5052, 4.23, 0.049, 330, 103, MYCOBACTERIUM TUBERCULOSIS TRANSCRIPTIONAL REGULATOR 
34, 2c05A, 0.5050, 3.69, 0.075, 135, 93, CRYSTAL STRUCTURES OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE INHIBITORS 5 -ATP AP3A AP4A AND AP5A
35, 1b1jA, 0.5048, 3.07, 0.101, 123, 89, CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT H13A.
36, 3zbwA, 0.5046, 3.02, 0.126, 120, 87, CRYSTAL STRUCTURE OF MURINE ANGIOGENIN-3
37, 2c01X, 0.5044, 3.69, 0.075, 135, 93, CRYSTAL STRUCTURES OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE INHIBITORS 5 -ATP AP3A AP4A AND AP5A
38, 1hi2A, 0.5044, 3.53, 0.077, 135, 91, EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - SULPHATE COMPLEX
39, 1kh8A, 0.5043, 3.40, 0.079, 125, 89, STRUCTURE OF A CIS-PROLINE (P114) TO GLYCINE VARIANT OF RIBONUCLEASE A
40, 5e13A, 0.5042, 3.73, 0.065, 135, 93, CRYSTAL STRUCTURE OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE TRIAZOLE DOUBLE-HEADED RIBONUCLEOSIDE 11C
41, 3zbvA, 0.5039, 2.93, 0.128, 118, 86, CRYSTAL STRUCTURE OF MURINE ANGIOGENIN-2
42, 9rsaA, 0.5037, 3.31, 0.068, 124, 88, CRYSTAL STRUCTURE OF TWO COVALENT NUCLEOSIDE DERIVATIVES OF RIBONUCLEASE A
43, 1gqvA, 0.5037, 3.69, 0.075, 135, 93, ATOMIC RESOLUTION (0.98A) STRUCTURE OF EOSINOPHIL-DERIVED NEUROTOXIN
44, 2j4tA, 0.5036, 2.92, 0.116, 119, 86, BIOLOGICAL AND STRUCTURAL FEATURES OF MURINE ANGIOGENIN-4 AN ANGIOGENIC PROTEIN
45, 1a4yE, 0.5036, 3.19, 0.114, 123, 88, RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX
46, 2vq8A, 0.5032, 3.31, 0.136, 128, 88, RNASE ZF-1A
47, 1hi3A, 0.5032, 3.79, 0.075, 135, 93, EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE-2 -5 -DIPHOSPHATE COMPLEX
48, 2c02A, 0.5029, 3.69, 0.075, 135, 93, CRYSTAL STRUCTURES OF EOSINOPHIL-DERIVED NEUROTOXIN IN COMPLEX WITH THE INHIBITORS 5 -ATP AP3A AP4A AND AP5A
49, 2e0lA, 0.5028, 3.61, 0.056, 128, 90, MUTANT HUMAN RIBONUCLEASE 1 (Q28L R31L R32L)
50, 2k11A, 0.5027, 3.55, 0.055, 127, 91, SOLUTION STRUCTURE OF HUMAN PANCREATIC RIBONUCLEASE
51, 2e0mA, 0.5025, 3.58, 0.056, 128, 90, MUTANT HUMAN RIBONUCLEASE 1 (T24L Q28L R31L R32L)
52, 1hi5A, 0.5025, 3.57, 0.077, 135, 91, EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE-5 -DIPHOSPHATE COMPLEX
53, 3ql2B, 0.5024, 3.37, 0.067, 124, 89, CRYSTAL STRUCTURE OF RIBONUCLEASE A VARIANT A4C/D83E/V118C
54, 1hi4A, 0.5024, 3.76, 0.065, 135, 93, EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE-3 -5 -DIPHOSPHATE COMPLEX
55, 2e0mB, 0.5022, 3.59, 0.056, 128, 90, MUTANT HUMAN RIBONUCLEASE 1 (T24L Q28L R31L R32L)
56, 1qmtA, 0.5022, 3.77, 0.075, 134, 93, RECOMBINANT HUMAN EOSINOPHIL CATIONIC PROTEIN
57, 4ahnA, 0.5021, 3.05, 0.114, 120, 88, R121H - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS
58, 1rnnE, 0.5021, 3.35, 0.068, 124, 88, RIBONUCLEASE A COMPLEX WITH CYTIDYLIC ACID (5 CMP) CRYSTALLIZED FROM 8M SODIUM FORMATE
59, 5m9mA, 0.5020, 3.01, 0.115, 120, 87, HUMAN ANGIOGENIN PD VARIANT Q77P
60, 2e0lB, 0.5018, 3.57, 0.056, 128, 90, MUTANT HUMAN RIBONUCLEASE 1 (Q28L R31L R32L)
61, 1rraA, 0.5018, 3.39, 0.056, 124, 89, RIBONUCLEASE A FROM RATTUS NORVEGICUS (COMMON RAT)
62, 8rsaA, 0.5017, 3.42, 0.067, 124, 89, CRYSTAL STRUCTURE OF TWO COVALENT NUCLEOSIDE DERIVATIVES OF RIBONUCLEASE A
63, 1h1hA, 0.5017, 3.69, 0.076, 134, 92, CRYSTAL STRUCTURE OF EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH 2 5 -ADP AT 2.0 A RESOLUTION REVEALS THE DETAILS OF THE RIBONUCLEOLYTIC ACTIVE SITE
64, 3zbwB, 0.5016, 3.20, 0.125, 121, 88, CRYSTAL STRUCTURE OF MURINE ANGIOGENIN-3
65, 5et4A, 0.5015, 3.35, 0.080, 124, 88, STRUCTURE OF RNASE A-K7H/R10H IN COMPLEX WITH 3 -CMP
66, 1rnqA, 0.5015, 3.36, 0.068, 124, 88, RIBONUCLEASE A CRYSTALLIZED FROM 8M SODIUM FORMATE
67, 2g8rB, 0.5014, 3.33, 0.068, 124, 88, THE CRYSTAL STRUCTURE OF THE RNASE A- 3-N-PIPERIDINE-4- CARBOXYL-3-DEOXY-ARA-URIDINE COMPLEX
68, 4peqA, 0.5012, 3.31, 0.068, 124, 88, STRUCTURE OF BOVINE RIBONUCLEASE INHIBITOR COMPLEXED WITH BOVINE RIBONUCLEASE I
69, 4a2oB, 0.5012, 3.36, 0.056, 133, 89, STRUCTURE OF THE HUMAN EOSINOPHIL CATIONIC PROTEIN IN COMPLEX WITH SULFATE ANIONS
70, 1hbyA, 0.5011, 3.08, 0.114, 122, 88, BINDING OF PHOSPHATE AND PYROPHOSPHATE IONS AT THE ACTIVE SITE OF HUMAN ANGIOGENIN AS REVEALED BY X-RAY CRYSTALLOGRAPHY
71, 4g90B, 0.5010, 3.33, 0.068, 124, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5E
72, 4g8yB, 0.5010, 3.34, 0.068, 124, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5B
73, 1rnmE, 0.5010, 3.37, 0.068, 124, 88, RIBONUCLEASE A COMPLEX WITH CYTIDYLIC ACID (5 CMP) CRYSTALLIZED FROM 80 percent AMMONIUM SULPHATE
74, 1a5qA, 0.5010, 3.34, 0.068, 124, 88, P93A VARIANT OF BOVINE PANCREATIC RIBONUCLEASE A
75, 1z6sB, 0.5009, 3.32, 0.068, 124, 88, RIBONUCLEASE A- AMP COMPLEX
76, 4oxfA, 0.5007, 3.46, 0.078, 134, 90, STRUCTURE OF ECP IN COMPLEX WITH CITRATE IONS AT 1.50 ANGSTROMS
77, 1ymnA, 0.5007, 3.41, 0.067, 124, 89, THE STUDY OF REDUCTIVE UNFOLDING PATHWAYS OF RNASE A (Y92L MUTANT)
78, 1aqpA, 0.5007, 3.37, 0.068, 124, 88, RIBONUCLEASE A COPPER COMPLEX
79, 2g4wB, 0.5006, 3.34, 0.068, 124, 88, ANOMALOUS SUBSTRUCTURE OF RIBONUCLEASE A (C2)
80, 2e0oA, 0.5006, 3.55, 0.056, 126, 90, MUTANT HUMAN RIBONUCLEASE 1 (V52L D53L N56L F59L)
81, 1jvvB, 0.5006, 3.33, 0.068, 124, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A (RETRO-SOAKED FORM)
82, 3rskA, 0.5005, 3.35, 0.068, 124, 88, STRUCTURE OF THE K7A/R10A/K66A VARIANT OF RIBONUCLEASE A
83, 1k59A, 0.5005, 3.14, 0.114, 122, 88, CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN VARIANT Q117G
84, 4oxbB, 0.5004, 3.38, 0.056, 133, 89, STRUCTURE OF ECP WITH SULPHATE ANIONS AT 1.50 ANGSTROMS
85, 4ahgA, 0.5004, 3.11, 0.136, 120, 88, S28N - ANGIOGENIN MUTANTS AND AMYOTROPHIC LATERAL SCLEROSIS - A BIOCHEMICAL AND BIOLOGICAL ANALYSIS
86, 1jvvA, 0.5004, 3.35, 0.068, 124, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A (RETRO-SOAKED FORM)
87, 1jvtB, 0.5004, 3.35, 0.068, 124, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A (LIGAND-FREE FORM)
88, 1afuB, 0.5004, 3.35, 0.068, 124, 88, STRUCTURE OF RIBONUCLEASE A AT 2.0 ANGSTROMS FROM MONOCLINIC CRYSTALS
89, 1afkB, 0.5003, 3.34, 0.068, 124, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A IN COMPLEX WITH 5 - DIPHOSPHOADENOSINE-3 -PHOSPHATE
90, 1jvtA, 0.5002, 3.35, 0.068, 124, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A (LIGAND-FREE FORM)
91, 3ev3B, 0.5001, 3.33, 0.068, 119, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A IN 70 percent T-BUTANOL
92, 2w5iB, 0.5001, 3.36, 0.068, 124, 88, RNASE A-AP3A COMPLEX
93, 1rnvA, 0.5001, 3.37, 0.068, 116, 88, REFINEMENT OF THE CRYSTAL STRUCTURE OF RIBONUCLEASE S. COMPARISON WITH AND BETWEEN THE VARIOUS RIBONUCLEASE A STRUCTURES
94, 1rbnA, 0.5001, 3.33, 0.068, 124, 88, THE STRUCTURE OF RIBONUCLEASE A DERIVATIVE II AT 2.1 ANGSTROMS RESOLUTION
95, 1eosB, 0.5001, 3.35, 0.068, 124, 88, CRYSTAL STRUCTURE OF RIBONUCLEASE A COMPLEXED WITH URIDYLYL(2 5 )GUANOSINE (PRODUCTIVE BINDING)
